These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11553463)

  • 1. Metalloantibodies: mercury(II)-dependent acyl transferases.
    Brümmer O; Hoffman TZ; Janda KD
    Bioorg Med Chem; 2001 Sep; 9(9):2253-7. PubMed ID: 11553463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of flexible and constrained haptens in eliciting antibody catalysts for paraoxon hydrolysis.
    Spivak DA; Hoffman TZ; Moore AH; Taylor MJ; Janda KD
    Bioorg Med Chem; 1999 Jun; 7(6):1145-50. PubMed ID: 10428386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient and selective p-nitrophenyl-ester-hydrolyzing antibodies elicited by a p-nitrobenzyl phosphonate hapten.
    Tawfik DS; Lindner AB; Chap R; Eshhar Z; Green BS
    Eur J Biochem; 1997 Mar; 244(2):619-26. PubMed ID: 9119032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A catalytic antibody against a tocopherol cyclase inhibitor.
    Manetsch R; Zheng L; Reymond MT; Woggon WD; Reymond JL
    Chemistry; 2004 May; 10(10):2487-506. PubMed ID: 15146522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hapten design for the generation of catalytic antibodies.
    Thomas NR
    Appl Biochem Biotechnol; 1994; 47(2-3):345-72. PubMed ID: 7944348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive immunization.
    Wirsching P; Ashley JA; Lo CH; Janda KD; Lerner RA
    Science; 1995 Dec; 270(5243):1775-82. PubMed ID: 8525366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Directed evolution governed by controlling the molecular recognition between an abzyme and its haptenic transition-state analog.
    Takahashi-Ando N; Kakinuma H; Fujii I; Nishi Y
    J Immunol Methods; 2004 Nov; 294(1-2):1-14. PubMed ID: 15604011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of an alpha,alpha-difluorophosphinate hapten for antibody-catalyzed hydrolysis of organophosphorus nerve agents.
    Vayron P; Renard PY; Valleix A; Mioskowski C
    Chemistry; 2000 Mar; 6(6):1050-63. PubMed ID: 10785826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in hydrolytic antibody activity by change in haptenic structure from phosphate to phosphonate with retention of a common leaving-group determinant: evidence for the 'flexibility' hypothesis.
    Gul S; Sonkaria S; Pinitglang S; Florez-Alvarez J; Hussain S; Thomas EW; Ostler EL; Gallacher G; Resmini M; Brocklehurst K
    Biochem J; 2003 Dec; 376(Pt 3):813-21. PubMed ID: 12946271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytic antibodies induced by a zwitterionic hapten.
    Tsumuraya T; Takazawa N; Tsunakawa A; Fleck R; Masamune S
    Chemistry; 2001 Sep; 7(17):3748-55. PubMed ID: 11575776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoabzymes: structurally and mechanistically similar catalytic antibodies from the same immunization.
    Angeles TS; Smith RG; Darsley MJ; Sugasawara R; Sanchez RI; Kenten J; Schultz PG; Martin MT
    Biochemistry; 1993 Nov; 32(45):12128-35. PubMed ID: 8218291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bait and switch hapten strategy generates catalytic antibodies for phosphodiester hydrolysis.
    Wentworth P; Liu Y; Wentworth AD; Fan P; Foley MJ; Janda KD
    Proc Natl Acad Sci U S A; 1998 May; 95(11):5971-5. PubMed ID: 9600901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How the anti-(metal chelate) antibody CHA255 is specific for the metal ion of its antigen: X-ray structures for two Fab'/hapten complexes with different metals in the chelate.
    Love RA; Villafranca JE; Aust RM; Nakamura KK; Jue RA; Major JG; Radhakrishnan R; Butler WF
    Biochemistry; 1993 Oct; 32(41):10950-9. PubMed ID: 8218161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient aldolase catalytic antibodies that use the enamine mechanism of natural enzymes.
    Wagner J; Lerner RA; Barbas CF
    Science; 1995 Dec; 270(5243):1797-800. PubMed ID: 8525368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspects of antibody-catalyzed primary amide hydrolysis.
    Titmas RC; Angeles TS; Sugasawara R; Aman N; Darsley MJ; Blackburn G; Martin MT
    Appl Biochem Biotechnol; 1994; 47(2-3):277-90; discussion 291-2. PubMed ID: 7944343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The scope of antibody catalysis.
    Jacobsen JR; Schultz PG
    Curr Opin Struct Biol; 1995 Dec; 5(6):818-24. PubMed ID: 8749371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune recognition, antigen design, and catalytic antibody production.
    Tramontano A
    Appl Biochem Biotechnol; 1994; 47(2-3):257-73; discussion 273-5. PubMed ID: 7944342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple reactive immunization towards the hydrolysis of organophosphorus nerve agents: hapten design and synthesis.
    Huang H; Han WG; Noodleman L; Grynszpan F
    Bioorg Med Chem; 2001 Dec; 9(12):3185-95. PubMed ID: 11711294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridoxal-5'-phosphate-dependent catalytic antibodies.
    Gramatikova S; Mouratou B; Stetefeld J; Mehta PK; Christen P
    J Immunol Methods; 2002 Nov; 269(1-2):99-110. PubMed ID: 12379355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies.
    Charbonnier JB; Carpenter E; Gigant B; Golinelli-Pimpaneau B; Eshhar Z; Green BS; Knossow M
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11721-5. PubMed ID: 8524836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.